Eledon Pharmaceuticals (ELDN) Change in Account Payables (2013 - 2017)
Eledon Pharmaceuticals (ELDN) posted Change in Account Payables of -$154000.0 for Q1 2017, up 66.23% on a QoQ basis from -$456000.0 in Q4 2016, and down 122.71% year-over-year from $678000.0 in Q1 2016.
Eledon Pharmaceuticals (ELDN) Change in Account Payables (2013 - 2017) Analysis & Trends
Eledon Pharmaceuticals' Change in Account Payables history runs 5 years deep, the most recent figure standing at -$154000.0 for Q1 2017.
- Quarterly Change in Account Payables fell 122.71% year-over-year to -$154000.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was -$1.6 million (down 4.01% YoY) and the FY2016 annual result came in at -$778000.0, down 275.62% from the prior year.
- Change in Account Payables was -$154000.0 for Q1 2017 at Eledon Pharmaceuticals, up from -$456000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.7 million in Q1 2015 and bottomed at -$1.8 million in Q2 2015.
- A 5-year average of -$46785.7 and a median of -$222500.0 in 2014 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2015 — Change in Account Payables soared 234.46% — and 2016, when it sank 5233.33%.
- Eledon Pharmaceuticals' Change in Account Payables stood at -$926000.0 in 2013, then slipped by 21.38% to -$1.1 million in 2014, then surged by 60.5% to -$444000.0 in 2015, then slipped by 2.7% to -$456000.0 in 2016, then surged by 66.23% to -$154000.0 in 2017.
- Business Quant data shows ELDN's Change in Account Payables at -$154000.0 in Q1 2017, -$456000.0 in Q4 2016, and -$960000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | - |
| 10 | Eledon Pharmaceuticals | 406.41 Mn | 406.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -154,000.00 |
| Mar 31, 2017 | -154,000.00 |
| Dec 31, 2016 | -456,000.00 |
| Dec 31, 2016 | -456,000.00 |
| Sep 30, 2016 | -960,000.00 |
| Sep 30, 2016 | -960,000.00 |
| Jun 30, 2016 | -40,000.00 |
| Jun 30, 2016 | -40,000.00 |
| Mar 31, 2016 | 678,000.00 |
| Mar 31, 2016 | 678,000.00 |
| Dec 31, 2015 | -444,000.00 |
| Dec 31, 2015 | -444,000.00 |
| Sep 30, 2015 | -18,000.00 |
| Sep 30, 2015 | -18,000.00 |
| Jun 30, 2015 | -1.76 Mn |
| Jun 30, 2015 | -1.76 Mn |
| Mar 31, 2015 | 2.67 Mn |
| Mar 31, 2015 | 2.67 Mn |
| Dec 31, 2014 | -1.12 Mn |
| Dec 31, 2014 | -1.12 Mn |